Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvar Agusti

Showing results (71-80 of 237) with videos related to

Pageof 24
Sort By:
Lancet (London, England)|May 7, 2015
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised managementPrescott G Woodruff, Alvar Agusti, Nicolas Roche, et al.
The Lancet. Respiratory Medicine|April 7, 2020
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?David M G Halpin, Rosa Faner, Oriol Sibila, et al.
NPJ Primary Care Respiratory Medicine|February 21, 2026
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist careAlvar Agusti, Aoife Kirk, Sara Panigone, et al.
The Lancet. Respiratory Medicine|August 10, 2015
The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Eric D Bateman, Helen K Reddel, Richard N van Zyl-Smit, et al.
COPD|May 10, 2016
Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled StudiesJadwiga A Wedzicha, Alvar Agusti, Gavin Donaldson, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary DiseaseDave Singh, Nicolas Roche, David Halpin, et al.
The European Respiratory Journal|October 18, 2014
Eosinophilic inflammation in COPD: prevalence and clinical characteristicsDave Singh, Umme Kolsum, Chris E Brightling, et al.
Plos One|February 25, 2021
Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot studyNuria Mendoza, Eva Rivas, Roberto Rodriguez-Roisin, et al.
The European Respiratory Journal|January 20, 2018
Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPDBernardino Alcázar-Navarrete, Oliverio Ruiz Rodríguez, Pablo Conde Baena, et al.
Archivos De Bronconeumologia|March 21, 2022
The 7 Cardinal Sins of COPD in SpainJosé Luis Izquierdo, Ciro Casanova, Bartolomé Celli, et al.
Pageof 24

Showing results (71-80 of 237) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|May 7, 2015
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised managementPrescott G Woodruff, Alvar Agusti, Nicolas Roche, et al.
The Lancet. Respiratory Medicine|April 7, 2020
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?David M G Halpin, Rosa Faner, Oriol Sibila, et al.
NPJ Primary Care Respiratory Medicine|February 21, 2026
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist careAlvar Agusti, Aoife Kirk, Sara Panigone, et al.
The Lancet. Respiratory Medicine|August 10, 2015
The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Eric D Bateman, Helen K Reddel, Richard N van Zyl-Smit, et al.
COPD|May 10, 2016
Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled StudiesJadwiga A Wedzicha, Alvar Agusti, Gavin Donaldson, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary DiseaseDave Singh, Nicolas Roche, David Halpin, et al.
The European Respiratory Journal|October 18, 2014
Eosinophilic inflammation in COPD: prevalence and clinical characteristicsDave Singh, Umme Kolsum, Chris E Brightling, et al.
Plos One|February 25, 2021
Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot studyNuria Mendoza, Eva Rivas, Roberto Rodriguez-Roisin, et al.
The European Respiratory Journal|January 20, 2018
Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPDBernardino Alcázar-Navarrete, Oliverio Ruiz Rodríguez, Pablo Conde Baena, et al.
Archivos De Bronconeumologia|March 21, 2022
The 7 Cardinal Sins of COPD in SpainJosé Luis Izquierdo, Ciro Casanova, Bartolomé Celli, et al.
Pageof 24